BRIEF-Nanthealth announces exclusive agreement with Oncotest-Teva By: Reuters: Company News December 06, 2016 at 15:47 PM EST * Under terms of agreement, Oncotest-Teva will have exclusive rights to distribute GPS cancer to physicians in Israel. Read More >> Related Stocks: Nanthealth Inc Teva Pharmaceutical Industries ADR